CCL18 and sarcoidosis: In our sarcoidosis cohort, CCL18 levels are increased in all patient groups, with a peak in fibrotic disease (with a median of 66,812 pg/mL vs. 59,317 pg/mL in the entire sarcoidosis cohort).